An interventional study of Thermography imaging in Malignancy, sponsored by Sheba Medical Center. Status unknown at 1 site in Israel. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-04-09.
Sponsored by Sheba Medical Center · Not applicable, Interventional, and Other
This research aims to investigate the correlation between tumor temperature difference and biological factors, such as size, metabolism, treatment response, and tumor aggressiveness.
In addition, normal tissue response to adjuvant radiation therapy in treated organs following surgery, will be evaluated.
During radiation session, the investigators would evaluate the changes that will be detected by thermal imaging and correlate them with visible side effects as well as with known tumor biology factors and skin-tumor distance.
9,365 studies on the registry are indexed under Neoplasms; 2,486 are open to participants now.
This study's planned enrollment of 80 is above the median of 50 across 7,250 interventional studies indexed under Neoplasms.
Browse Neoplasms studies →Sheba Medical Center is the lead sponsor of 660 studies on the registry; 63 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
In this study, patients undergoing radiation treatment will undergo thermography imaging during radiation treatment course. Patients will be evaluated with thermography imaging every 5 fraction of radiation, starting prior to the first radiation treatment, periodically, until the end of radiation therapy (a period of several weeks).
Other: Thermography imaging
Thermography imaging of the treated - irradiated body area.
Measurement of IR : Infra-Red radiation emitted at wavelengths 0.8-1nm
Mathematical analysis of the thermic image
Time frame: Before the first fraction of radiation and every 5 fraction until the end of radiation therapy, approximately 4-5 weeks.
Dermal side effects during radiation therapy using CTCAE v4.0
Clinical assesment of the side effects by physician.
Time frame: Before the first fraction of radiation and every 5 fraction until the end of radiation therapy, approximately 4-5 weeks.
US/CT scans
The tumor size will be measures to evaluate the efficacy of the radiation treatment.
Time frame: The tumor size in cubic cm will be mesured prior to first fraction of radiation, and 2 weeks following the end of radiation session. Time for final evaluation: approximately 6-7 weeks.
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sheba Medical Center